1. Home
  2. TENX vs DALN Comparison

TENX vs DALN Comparison

Compare TENX & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • DALN
  • Stock Information
  • Founded
  • TENX 1967
  • DALN 1954
  • Country
  • TENX United States
  • DALN United States
  • Employees
  • TENX N/A
  • DALN N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • DALN Newspapers/Magazines
  • Sector
  • TENX Health Care
  • DALN Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • DALN Nasdaq
  • Market Cap
  • TENX 21.8M
  • DALN 24.6M
  • IPO Year
  • TENX N/A
  • DALN 2008
  • Fundamental
  • Price
  • TENX $6.37
  • DALN $6.79
  • Analyst Decision
  • TENX Strong Buy
  • DALN
  • Analyst Count
  • TENX 4
  • DALN 0
  • Target Price
  • TENX $20.67
  • DALN N/A
  • AVG Volume (30 Days)
  • TENX 38.7K
  • DALN 54.4K
  • Earning Date
  • TENX 11-13-2024
  • DALN 03-05-2025
  • Dividend Yield
  • TENX N/A
  • DALN 2.36%
  • EPS Growth
  • TENX N/A
  • DALN N/A
  • EPS
  • TENX N/A
  • DALN N/A
  • Revenue
  • TENX N/A
  • DALN $128,286,000.00
  • Revenue This Year
  • TENX N/A
  • DALN N/A
  • Revenue Next Year
  • TENX N/A
  • DALN N/A
  • P/E Ratio
  • TENX N/A
  • DALN N/A
  • Revenue Growth
  • TENX N/A
  • DALN N/A
  • 52 Week Low
  • TENX $2.77
  • DALN $2.98
  • 52 Week High
  • TENX $21.46
  • DALN $7.86
  • Technical
  • Relative Strength Index (RSI)
  • TENX 57.59
  • DALN 54.49
  • Support Level
  • TENX $5.92
  • DALN $6.75
  • Resistance Level
  • TENX $6.65
  • DALN $7.19
  • Average True Range (ATR)
  • TENX 0.43
  • DALN 0.34
  • MACD
  • TENX -0.02
  • DALN -0.09
  • Stochastic Oscillator
  • TENX 56.21
  • DALN 8.41

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.

Share on Social Networks: